L-ELISA for human Granzyme A protein quantifies Hu Granzyme A in cell culture medium, plasma, or human serum. The dosage will recognize only natural and recombinant human Granzyme A.
L-ELISA for human Granzyme A protein quantifies Hu Granzyme A in cell culture medium, plasma, or human serum. The dosage will recognize only natural and recombinant human Granzyme A.
Method principle
L的ELISA (immuno-enzymatic test) in solid phase sandwiches of human Granzyme A is designed to measure the amount of the target bound between a pair of matched antibodies. A target-specific antibody was pre-vested in the wells of the supplied microplate. Samples, standards or controls are then added to these wells and bound to immobilized antibody (capture). The sandwich is formed by adding the second antibody (detector), binding to the target on a different epitope from the capture antibody. A conjugate enzyme was incorporated into the assay. After incubation and washing steps to remove the microplate from the non-bonded substances, a substrate solution reacts with the enzyme-antibodies-target complex to produce a measurable signal. The intensity of this coloured product is directly proportional to the concentration of TP (p) present in the original sample.
Strict validation
Each batch manufactured from this ELISA kit is tested according to its quality for criteria such as sensitivity, specificity, accuracy and batch-to-batch consistency. See the product manual for more information on validation.
Granzyme A (GzmA) is the most abundant serine protease in the cytotoxic granules of killer cells. GzmA activates a new programmed cell death pathway that begins in mitochondria, where NDUFS3 cleavage in electron transport complex I disrupts mitochondrial metabolism and generates reactive oxygen species (ROS). GzmA also targets other nuclear proteins that are important for degradation, including histones, laminates that maintain the nuclear envelope and several key repair proteins for damage caused by DNA (Ku70, PARP-1). GzmA also has pro-inflammatory activity; it activates pro-interleukin-1? And may also have other pro-inflammatory effects that remain to be clarified.
Sensitivity
Sensitivity of the dosage: 0.73 pg/ml.
Measurement range
Dose range: 7.8-500 pg/ml.
Duration of dosing
Total duration of dosing: 3 h 30 min.
Reproducibility
Coefficient of intra-dose variation 4.9%, inter-dose 8.5%.
Technical specifications
| General |
| Brand | Invitrogen |
| Supplier ref. (Fisher Scientific) | 15964204 |
| Specifications |
| Accession number | P12544 |
| Dose range | 7.8-500 pg/ml |
| Sensitivity of the dosage | 0.73 pg/ml |
| Conjugate | Biotin |
| Product type | Kit ELISA |
| Type of sample | Cellular lysates, Serum, Surnatant, Surnatant |
| Target species | Human |
| For use with (equipment) | Colorimetric microplate reader |
| Genetic identification (Enter) | 3001 |
| Gene symbol(s) | GZMA |
| Coefficient of inter-dose variation | 8.5% |
| Coefficient of intra-dose variation | 4.9% |
| Contents of kits | 96-well pre-coated plate, Standard (2 vials), Standard dilution stamp, Biotinylated detection anticorps, Streptavidine HRP, HRP diluent, Wash pad, Chromagen, Stop solution, Adhesive plate covers |
| Marker or dye | HRP |
| Quantity | 96 tests |
| Regulatory status | RUO |
| Target | Human |
| Test time | 1 h 20 min |
| Physical characteristics |
| Volume of sample | Serum, 50 μl; plasma, 50 μl; cell lysate, 50 μl; supernatant, 50 μl |
| Storage and shipping |
| Storage conditions | 2°C to 8°C |
| Total duration of dosing | 3 h 30 min |
Origin and customs
| Manufacturer ref. | BMS2232 |
|---|
| Country of origin | Autriche |
|---|
| HS customs code | 3002 15 00 00 |
|---|
A question or a specific configuration?
Contact us for a quote.